EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inflammation Targeting Lymphocyte Apoptotic Body Hybrid Nanovesicles Alleviate Ovarian Inflammation in Polycystic Ovary Syndrome

Xuezhi Shen, Qifan Yu, Yanhong Shen, Bufan Zhang, Xiaohang Ye, Yuewen Ying, Yiqing Wu, Xiao Sun, Dan Zhang iD, Yifeng Liu iD

ACS Nano · 2026

DOI: 10.1021/acsnano.6c06395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Xuezhi Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education) and Department of Reproductive Endocri…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Inflammation, Ovary, Anti-Inflammatory Agents. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education of the People's Republic of China, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sustained inflammation localized in the ovarian microenvironment has been implicated as a key pathophysiological driver of polycystic ovary syndrome (PCOS), primarily disrupting normal folliculogenesis and arresting ovulation. Current therapies generally fail to address this underlying pathology due to their limitation in precisely targeting or modulating the ovarian immune microenvironment. Consequently, inflammation-induced tissue damage remains largely unresolved. To overcome this limitation, we developed a biomimetic hybrid nanovesicle termed TLAB@ATS. This platform combines anti-inflammatory T cell-derived apoptotic bodies (AB) with reactive oxygen species (ROS)-responsive thioketal (TK)-linked lipids for the targeted delivery of artesunate (ATS). Leveraging the natural homing ability of AB, TLAB@ATS specifically accumulates in ovarian inflammation, where elevated ROS levels induce cleavage of the TK linkers to trigger the on-demand release of ATS. We found that TLAB@ATS suppresses the expression of pro-inflammatory cytokines, significantly reduces ovarian oxidative stress and inflammatory immune cell infiltration, and thereby restores endocrine balance, alleviates ovarian inflammatory infiltration, and promotes normal folliculogenesis. Collectively, this tailored nanoplatform provides a targeted approach for alleviating ovarian inflammation in PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInflammationOvaryAnti-Inflammatory AgentsNanoparticlesLymphocytesFemaleAnimalsHumansReactive Oxygen SpeciesApoptosisOxidative StressMice

Stichwörter der Autor:innen

apoptotic bodiesinflammatory microenvironmentnanovesiclepolycystic ovary syndrometargeted delivery

Substanzen

Reactive Oxygen SpeciesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education) and Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Zhe…
  • Zhejiang Provincial Clinical Research Center for Birth Defect Control, Women's Hospital, Zhejiang University School of Medicine, Zhejiang, 310006, China.
  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices, Soochow University, Jiangsu, 215123, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai200433, China.

ORCID-Profile: Dan Zhang, Yifeng Liu

Förderung

  • Ministry of Education of the People's Republic of China
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Shen, X., Yu, Q., Shen, Y., Zhang, B., Ye, X., Ying, Y., Wu, Y., Sun, X., Zhang, D., & Liu, Y. (2026). Inflammation Targeting Lymphocyte Apoptotic Body Hybrid Nanovesicles Alleviate Ovarian Inflammation in Polycystic Ovary Syndrome. ACS Nano. https://doi.org/10.1021/acsnano.6c06395

Vancouver

Shen X, Yu Q, Shen Y, Zhang B, Ye X, Ying Y, et al. Inflammation Targeting Lymphocyte Apoptotic Body Hybrid Nanovesicles Alleviate Ovarian Inflammation in Polycystic Ovary Syndrome. ACS Nano. 2026. doi:10.1021/acsnano.6c06395

BibTeX
@article{Shen2026,
  author = {Shen, Xuezhi and Yu, Qifan and Shen, Yanhong and Zhang, Bufan and Ye, Xiaohang and Ying, Yuewen and Wu, Yiqing and Sun, Xiao and Zhang, Dan and Liu, Yifeng},
  title = {Inflammation Targeting Lymphocyte Apoptotic Body Hybrid Nanovesicles Alleviate Ovarian Inflammation in Polycystic Ovary Syndrome},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c06395}
}
Kostenlos starten →